Takara Bio Management

Management criteria checks 2/4

Takara Bio's CEO is Koichi Nakao, appointed in May 2009, has a tenure of 15.58 years. directly owns 0.061% of the company’s shares, worth ¥73.10M. The average tenure of the management team and the board of directors is 2.9 years and 5.5 years respectively.

Key information

Koichi Nakao

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure15.6yrs
CEO ownership0.06%
Management average tenure2.9yrs
Board average tenure5.5yrs

Recent management updates

Recent updates

Some May Be Optimistic About Takara Bio's (TSE:4974) Earnings

Nov 20
Some May Be Optimistic About Takara Bio's (TSE:4974) Earnings

Takara Bio (TSE:4974) Is Paying Out A Dividend Of ¥17.00

Nov 11
Takara Bio (TSE:4974) Is Paying Out A Dividend Of ¥17.00

CEO

Koichi Nakao (62 yo)

15.6yrs

Tenure

Mr. Koichi Nakao was Director & President of Takara Bio Inc. from May 2009 to April 2020. Mr. Nakao was Director of Takara Bio Inc. from April 2002 to May 2009. He serves as Senior Managing Executive Offic...


Leadership Team

NamePositionTenureCompensationOwnership
Koichi Nakao
CEO, President & Representative Director15.6yrsno data0.061%
¥ 73.1m
Yoh Hamaoka
CFO, Senior Executive Officer & Director2.9yrsno data0.014%
¥ 16.9m
Takuya Kakemi
Executive Officerno datano datano data
Akira Kodera
Managing Executive Officer & Head of Sales Division1.9yrsno datano data
Noritaka Nishiwaki
Executive Officerno datano datano data
Tsuyoshi Miyamura
Senior Managing Director & Director10.5yrsno data0.011%
¥ 13.4m
Junichi Mineno
VP, Executive Officer & Director2.9yrsno data0.012%
¥ 14.3m
Katsuhiko Kusakabe
CMCO, Senior Executive Officer & Director7.5yrsno data0.0040%
¥ 4.8m
Andrew Farmer
Head of Research and Developmentno datano datano data
Kyoko Nakajima
Managing Executive Officer & Head of SCM Division1.9yrsno datano data
Ikuei Nukaya
Managing Executive Officer & Head of Quality Control Headquartersless than a yearno datano data

2.9yrs

Average Tenure

62yo

Average Age

Experienced Management: 4974's management team is considered experienced (2.9 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Koichi Nakao
CEO, President & Representative Director22.7yrsno data0.061%
¥ 73.1m
Yoh Hamaoka
CFO, Senior Executive Officer & Director3.5yrsno data0.014%
¥ 16.9m
Tsuyoshi Miyamura
Senior Managing Director & Director6.5yrsno data0.011%
¥ 13.4m
Junichi Mineno
VP, Executive Officer & Director10.5yrsno data0.012%
¥ 14.3m
Katsuhiko Kusakabe
CMCO, Senior Executive Officer & Director1.9yrsno data0.0040%
¥ 4.8m
Mutsumi Kimura
Director2.5yrsno data0.043%
¥ 51.1m
Kazuko Kimura
Independent External Director5.5yrsno datano data
Nobuko Kawashima
Independent External Director8.5yrsno datano data
Yasuo Himeiwa
Independent Outside Audit & Supervisory Board Memberno datano datano data
Kunihiko Kamada
Independent Outside Audit & Supervisory Board Memberno datano datano data
Masaaki Makikawa
Independent Outside Audit & Supervisory Board Memberno datano datano data
Noriomi Matsumura
Independent External Director4.5yrsno datano data

5.5yrs

Average Tenure

62.5yo

Average Age

Experienced Board: 4974's board of directors are considered experienced (5.5 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 10:29
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Takara Bio Inc. is covered by 10 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Hidemaru YamaguchiCitigroup Inc
Yen Ting ChenCredit Suisse
Kiyokazu YamazakiIchiyoshi Research Institute Inc.